National Cancer Institute; Notice of Meeting, 9866-9867 [2016-04103]
Download as PDF
<![CDATA[
9866
Federal Register / Vol. 81, No. 38 / Friday, February 26, 2016 / Notices
comment. The Eunice Kennedy Shriver
National Institute of Child Health and
Human Development (NICHD), National
Institutes of Health, may not conduct or
sponsor, and the respondent is not
required to respond to, an information
collection that has been extended,
revised, or implemented on or after
October 1, 1995, unless it displays a
currently valid OMB control number.
Direct Comments to OMB: Written
comments and/or suggestions regarding
the item(s) contained in this notice,
especially regarding the estimated
public burden and associated response
time, should be directed to the: Office
of Management and Budget, Office of
Regulatory Affairs, OIRA_submission@
omb.eop.gov or by fax to 202–395–6974,
Attention: NIH Desk Officer.
DATES: Comment Due Date: Comments
regarding this information collection are
best assured of having their full effect if
received within 30 days of the date of
this publication.
FOR FURTHER INFORMATION CONTACT: To
obtain a copy of the data collection
plans and instruments, or request more
information on the proposed project,
contact: Rohan Hazra, M.D., Eunice
Kennedy Shriver National Institute of
Child Health and Human Development
(NICHD), National Institutes of Health,
6100 Executive Blvd., Room 4B11,
Bethesda, MD 20892–7510, or call nontoll-free number (301)-435–6868 or
Email your request, including your
address to: hazrar@mail.nih.gov. Formal
requests for additional plans and
information about the studies and data
archived in NICHD DASH without
creating an account. Users who wish to
submit or request research study data
must register for an account.
Information will be collected from
those wishing to create an account,
sufficient to identify them as unique
Users. Those submitting or requesting
data will be required to provide
additional supporting information to
ensure proper use and security of
NICHD DASH data. The information
collected is limited to the essential data
required to ensure that the management
of Users in NICHD DASH is efficient
and the sharing of data among
investigators is effective. The primary
uses of the information collected from
Users by NICHD will be to:
• Communicate with the Users with
regards to their data submission or
requests
• Monitor data submissions and data
requests
• Notify interested recipients of
updates to data stored in NICHD DASH
• Help NICHD understand the use of
NICHD DASH data by the research
community
There is no plan to publish the data
collected under this request.
OMB approval is requested for 3
years. There are no costs to respondents
other than their time. The total
estimated annualized burden hours are
142.
instruments must be requested in
writing.
Proposed Collection: Data and
Specimen Hub (DASH), 0925–NEW,
Eunice Kennedy Shriver National
Institute of Child Health and Human
Development (NICHD), National
Institutes of Health (NIH).
Need and Use of Information
Collection: The NICHD Data and
Specimen Hub (DASH) is being
established by NICHD as a data sharing
mechanism for biomedical research
investigators. It will serve as a
centralized resource for investigators to
store and access de-identified data from
studies funded by NICHD. The potential
for public benefit to be achieved
through sharing research study data for
secondary analysis is significant. NICHD
DASH supports NICHD’s mission to
ensure that every person is born healthy
and wanted, that women suffer no
harmful effects from reproductive
processes, and that all children have the
chance to achieve their full potential for
healthy and productive lives, free from
disease or disability, and to ensure the
health, productivity, independence, and
well-being of all people through optimal
rehabilitation. Data sharing and reuse
will promote testing of new hypotheses
from data already collected, facilitate
trans-disciplinary collaboration,
accelerate scientific findings and enable
NICHD to maximize the return on its
investments in research.
Anyone can access NICHD DASH to
browse and view descriptive
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Form
Frequency of
response
Average time
per response
(in hours)
Total annual
burden hour
User Registration .............................................................................................
Data Submission ..............................................................................................
Data Request ...................................................................................................
120
36
60
1
1
1
5/60
2
1
10
72
60
Total ..........................................................................................................
120
216
........................
142
Dated: February 17, 2016.
Sarah L. Glavin,
Project Clearance Liaison, NICHD, NIH.
[FR Doc. 2016–04178 Filed 2–25–16; 8:45 am]
mstockstill on DSK4VPTVN1PROD with NOTICES
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Meeting
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
VerDate Sep<11>2014
20:41 Feb 25, 2016
Jkt 238001
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the
National Cancer Institute Board of
Scientific Advisors. The meeting will be
open to the public, with attendance
limited to space available. Individuals
who plan to attend and need special
assistance, such as sign language
interpretation or other reasonable
accommodations, should notify the
Contact Person listed below in advance
of the meeting. The meeting will also be
videocast and can be accessed from the
NIH Videocasting and Podcasting Web
site (https://videocast.nih.gov/).
PO 00000
Frm 00063
Fmt 4703
Sfmt 4703
Name of Committee: National Cancer
Institute Board of Scientific Advisors.
Date: March 29, 2016.
Time: 8:30 a.m. to 5:00 p.m.
Agenda: Director’s Report: Ongoing and
New Business; Reports of Program Review
Group(s); Budget Presentations; Reports of
Special Initiatives; RFA and RFP Concept
Reviews; and Scientific Presentations.
Place: National Institutes of Health, 31
Center Drive, Building 31, C-Wing, 6th Floor,
Room 10, Bethesda, MD 20892.
Contact Person: Paulette S. Gray, Ph.D.,
Director, Division of Extramural Activities,
National Cancer Institute—Shady Grove,
National Institutes of Health, 9609 Medical
Center Drive, 7th Floor, Rm. 7W444,
E:\FR\FM\26FEN1.SGM
26FEN1
Federal Register / Vol. 81, No. 38 / Friday, February 26, 2016 / Notices
Bethesda, MD 20892, 240–276–6340, grayp@
mail.nih.gov.
Name of Committee: National Cancer
Institute Board of Scientific Advisors.
Date: March 30, 2016.
Time: 8:30 a.m. to 12:00 p.m.
Agenda: Director’s Report: Ongoing and
New Business; Reports of Program Review
Group(s); Budget Presentations; Reports of
Special Initiatives; RFA and RFP Concept
Reviews; and Scientific Presentations.
Place: National Institutes of Health, 31
Center Drive, Building 31, C-Wing, 6th Floor,
Room 10, Bethesda, MD 20892.
Contact Person: Paulette S. Gray, Ph.D.,
Director, Division of Extramural Activities,
National Cancer Institute—Shady Grove,
National Institutes of Health, 9609 Medical
Center Drive, 7th Floor, Rm. 7W444,
Bethesda, MD 20892, 240–276–6340, grayp@
mail.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit. Information is also available on the
Institute’s/Center’s home page: https://
deainfo.nci.nih.gov/advisory/bsa/bsa.htm,
where an agenda and any additional
information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: February 22, 2016.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2016–04103 Filed 2–25–16; 8:45 am]
BILLING CODE 4140–01–P
mstockstill on DSK4VPTVN1PROD with NOTICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
VerDate Sep<11>2014
20:41 Feb 25, 2016
Jkt 238001
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Immune Mechanisms.
Date: March 4, 2016.
Time: 3:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Jian Wang, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4095D,
MSC 7812, Bethesda, MD 20892, (301) 435–
2778, wangjia@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Neurochemistry.
Date: March 7, 2016.
Time: 1:00 p.m. to 2:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Richard D. Crosland,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4190,
MSC 7850, Bethesda, MD 20892, 301–435–
1220, crosland@nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Interventions to Prevent and Treat
Addictions.
Date: March 8, 2016.
Time: 10:00 a.m. to 11:00 a.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Miriam Mintzer, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3108,
Bethesda, MD 20892, 301–523–0646,
mintzermz@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
PO 00000
Frm 00064
Fmt 4703
Sfmt 4703
9867
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Clinical
Molecular Imaging Probe Development.
Date: March 9, 2016.
Time: 3:30 p.m. to 4:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda MD 20892,
(Telephone Conference Call).
Contact Person: David L. Williams, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5110,
MSC 7854, Bethesda, MD 20892, (301) 435–
1174, williamsdl2@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: February 22, 2016.
Anna Snouffer,
Deputy Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2016–04104 Filed 2–25–16; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Draft National Toxicology Program
Monograph on Immunotoxicity
Associated With Exposure to
Perfluorooctanoic Acid or
Perfluorooctane Sulfonate; Availability
of Document; Request for Comments;
Notice of Meeting
The notice announces a
meeting to peer review the draft NTP
monograph on immunotoxicity
associated with exposure to
perfluorooctanoic acid (PFOA) or
perfluorooctane sulfonate (PFOS). The
Office of Health Assessment and
Translation, Division of the National
Toxicology Program (DNTP), National
Institute of Environmental Health
Sciences (NIEHS), prepared the draft
NTP monograph. The peer review
meeting is open to the public.
Registration is requested for both public
attendance and oral comment and
required to access the webcast.
Information about the meeting and
registration are available at https://
ntp.niehs.nih.gov/go/36639.
DATES: Meeting: July 19, 2016, 9:00 a.m.
to approximately 2:00 p.m. Eastern
Daylight Time (EDT).
Document Availability: The draft NTP
monograph should be available by June
SUMMARY:
E:\FR\FM\26FEN1.SGM
26FEN1
]]>Agencies
[Federal Register Volume 81, Number 38 (Friday, February 26, 2016)]
[Notices]
[Pages 9866-9867]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-04103]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Meeting
Pursuant to section 10(a) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of a meeting of the
National Cancer Institute Board of Scientific Advisors. The meeting
will be open to the public, with attendance limited to space available.
Individuals who plan to attend and need special assistance, such as
sign language interpretation or other reasonable accommodations, should
notify the Contact Person listed below in advance of the meeting. The
meeting will also be videocast and can be accessed from the NIH
Videocasting and Podcasting Web site (https://videocast.nih.gov/).
Name of Committee: National Cancer Institute Board of Scientific
Advisors.
Date: March 29, 2016.
Time: 8:30 a.m. to 5:00 p.m.
Agenda: Director's Report: Ongoing and New Business; Reports of
Program Review Group(s); Budget Presentations; Reports of Special
Initiatives; RFA and RFP Concept Reviews; and Scientific
Presentations.
Place: National Institutes of Health, 31 Center Drive, Building
31, C-Wing, 6th Floor, Room 10, Bethesda, MD 20892.
Contact Person: Paulette S. Gray, Ph.D., Director, Division of
Extramural Activities, National Cancer Institute--Shady Grove,
National Institutes of Health, 9609 Medical Center Drive, 7th Floor,
Rm. 7W444,
[[Page 9867]]
Bethesda, MD 20892, 240-276-6340, grayp@mail.nih.gov.
Name of Committee: National Cancer Institute Board of Scientific
Advisors.
Date: March 30, 2016.
Time: 8:30 a.m. to 12:00 p.m.
Agenda: Director's Report: Ongoing and New Business; Reports of
Program Review Group(s); Budget Presentations; Reports of Special
Initiatives; RFA and RFP Concept Reviews; and Scientific
Presentations.
Place: National Institutes of Health, 31 Center Drive, Building
31, C-Wing, 6th Floor, Room 10, Bethesda, MD 20892.
Contact Person: Paulette S. Gray, Ph.D., Director, Division of
Extramural Activities, National Cancer Institute--Shady Grove,
National Institutes of Health, 9609 Medical Center Drive, 7th Floor,
Rm. 7W444, Bethesda, MD 20892, 240-276-6340, grayp@mail.nih.gov.
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has instituted stringent
procedures for entrance onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles will be inspected
before being allowed on campus. Visitors will be asked to show one
form of identification (for example, a government-issued photo ID,
driver's license, or passport) and to state the purpose of their
visit. Information is also available on the Institute's/Center's
home page: https://deainfo.nci.nih.gov/advisory/bsa/bsa.htm, where an
agenda and any additional information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.392,
Cancer Construction; 93.393, Cancer Cause and Prevention Research;
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer
Control, National Institutes of Health, HHS)
Dated: February 22, 2016.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2016-04103 Filed 2-25-16; 8:45 am]
BILLING CODE 4140-01-P
